ABBOTT IRELAND ARCHITECT HBSAG REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
|
Back to Search Results |
|
Catalog Number 06C36-76 |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Type
malfunction
|
Manufacturer Narrative
|
This report is being filed on an international product, architect (b)(6), list 6c36, that has a similar product distributed in the us, list number 4p53.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Additional information section 1 patient information: patient 1 - (b)(6) year old male.Patient 2 - (b)(6) year old male.Patient 3 - (b)(6) year old male.Patient 4 - (b)(6) year old female.
|
|
Event Description
|
The customer obtained false negative architect (b)(6) results for four samples.The customer indicated the samples were positive for dna.The following results were provided: patient 1 - (b)(6) year old male with chronic (b)(6): 0 and 0.01 iu/ml on two architect analyzers and 0 iu/ml on alinity (b)(6).Patient 2 - (b)(6) year old male with liver fibrosis: 0.04 and 0.02 iu/ml on two architect analyzers; alinity (b)(6).Patient 3 - (b)(6) year old male with liver transplant: 0 and 0 iu/ml on two architect analyzers and 0 iu/ml on alinity (b)(6).Patient 4 - (b)(6) year old female with chronic (b)(6): 0.03 and 0.02 iu/ml on two architect analyzers and 0.02 iu/ml on the alinity (b)(6).No impact to patient management was reported.
|
|
Manufacturer Narrative
|
The complaint investigation included a search for similar complaints, and review of complaint text, trending data, labeling, and device history records.In-house testing of reagent lot 14116fn00 was also completed.Return testing was not completed as returns were not available.Review of trending data did not identify any trends for the issue.Device history record review for reagent lot 14116fn00 did not identify any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.In house testing of panels which mimic patient samples was completed using retained kits of the complaint lot.All specifications were met indicating that the lot is performing acceptably.Based on the investigation, no systemic issue or deficiency of the architect hbsag assay, lot number 14116fn00 was identified.
|
|
Event Description
|
The customer obtained false negative architect hbsag results for four samples.The customer indicated the samples were positive for dna.The following results were provided: patient 1 - 54 year old male with chronic hepatitis b: 0 and 0.01 iu/ml on two architect analyzers and 0 iu/ml on alinity hbsag.Hbeab and hbcab and dna positive.Patient 2 - 30 yea old male with liver fibrosis: 0.04 and 0.02 iu/ml on two architect analyzers; alinity hbsag 0.05 iu/ml positive, hbeag, hbcab and dna positive patient 3 - 54 year old male with liver transplant: 0 and 0 iu/ml on two architect analyzers and 0 iu/ml on alinity hbsag; positive results for hbsab, hbeab, hbcab and dna.Patient 4 - 32 year old female with chronic hepatitis b: 0.03 and 0.02 iu/ml on two architect analyzers and 0.02 iu/ml on the alinity hbsag; positive results for hbcab and dna.No impact to patient management was reported.
|
|
Search Alerts/Recalls
|
|
|